In our experiments, CT26/NIS-cODC tumors of bortezomib-treated animals displayed clearly increased radioiodine uptake on PET and showed strong NIS expression on tissue staining, which demonstrates the capacity of our reporter to noninvasively image tumor response to proteasome inhibition. Here, SLC5A5 is linked to neoplasm.